Evidence map›Paper›PMID 37237543›Full record

ArticleBiology2023

Reduction in mRNA Expression of the Neutrophil Chemoattract Factor CXCL1 in

Hana M Zegallai, Kangmin Duan, Grant M Hatch

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Effects of Cannabidiol on TAFAZZIN-Deficient B-Lymphoblastoid Cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Hana M ZegallaiDepartment of Pharmacology & Therapeutics, Children's Hospital Research Institute of Manitoba, University of Manitoba 753 McDermot Avenue, Winnipeg, MB R3E0T6, Canada.
Kangmin DuanDepartment of Oral Biology, University of Manitoba, Winnipeg, MB R3E0T6, Canada.ORCID 0000-0002-3016-786X
Grant M HatchDepartment of Pharmacology & Therapeutics, Children's Hospital Research Institute of Manitoba, University of Manitoba 753 McDermot Avenue, Winnipeg, MB R3E0T6, Canada.
Children's Hospital Research Institute of Manitoba · CAUniversity of Manitoba · CA

Funding

Natural Sciences and Engineering Research Council RGPIN-05368-2019Natural Sciences and Engineering Research Council RGPIN-05864-2019
6 · The paper itself

Abstract

Barth Syndrome (BTHS) is a rare X-linked genetic disease caused by a mutation in the

Indexed as

bacterial activationBarth Syndromecardiolipinchemokine (C-X-C motif) ligand 1CXCL1human B lymphoblastsimmune biologyPseudomonas aeruginosaTAFAZZINX-linked genetic disease

Identifiers

PMID37237543
PMCPMC10215251
OpenAlexW4377043095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.